Chartreusin

Chartreusin is an antibiotic that is active against certain Gram-positive organisms and mycobacteria. Chartreusin is also active against the Micrococcus fiyogenes v. aureus phage[1].

Product Specifications

CAS Number

[6377-18-0]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Antibiotic; Bacterial

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/chartreusin.html

Solubility

10 mM in DMSO

Smiles

OC1=C(C=CC=C2O[C@H]3[C@@H]([C@H]([C@@H](O)[C@@H](C)O3)O)O[C@]4([H])[C@@H]([C@H]([C@@H](O)[C@@H](C)O4)OC)O)C2=C5C(C6=C(O7)C=CC(C)=C6C(O5)=O)=C1C7=O

Molecular Formula

C32H32O14

Molecular Weight

640.59

Precautions

H302, H315, H319, H335

References & Citations

[1]Leach B E, et al. Chartreusin, a new antibiotic produced by Streptomyces chartreusis, a new species. Journal of the American Chemical Society, 1953, 75 (16) : 4011-4012.